News Analysis Sinovac Biotech is the largest producer of the COVID-19 vaccine in China. Despite concerns over the efficacy of the Sinovac vaccine, the biopharmaceutical company’s subsidiary made a net profit of $1.67 billion in the first quarter of this year alone. While Sinovac is generating large profits, it’s noteworthy that some of its investors have strong political…

The Chinese Communist Party (CCP) is pushing hard to get people administered with domestic vaccines, and many local governments or entities are using various tactics to accomplish this political mission. Recently, Shanghai was reported to give away bonuses and various items for people receiving a domestic vaccine, while a property management company posted a notice…

The Hong Kong government recently rolled out a large-scale vaccination plan against the CCP (Chinese Communist Party) virus, commonly known as COVID-19, but it’s been mired by frequent reports of serious adverse reactions. In just one month, 13 people died in Hong Kong after being inoculated, 11 of whom had been injected with the Sinovac vaccine,…

Hong Kong has formally approved China’s Sinovac vaccine for emergency use, the city’s Health Secretary announced Thursday.

NEW DELHI—India and China unwittingly turned rivals on the development of COVID-19 vaccines after competing Brazilian politicians ended up inviting China’s Sinovac and India’s Serum Institute amid delays in the production of Brazil’s own vaccine. Meanwhile, the country’s private clinics have turned to another Indian vaccine producer, Bharat Biotech, for 5 million doses of its…

NEW DELHI—Competing Brazilian politicians have ended up inviting both China’s Sinovac and India’s Serum Institute for COVID-19 vaccines amid delays in the production of Brazil’s own vaccine. Meanwhile, the country’s private clinics have turned to another Indian vaccine producer, Bharat Biotech, for 5 million doses of its COVID-19 vaccine called Covaxin. Brazil has the third-highest…